Login
Subscribe
Take a FREE Trial
About Us
Contact us
RSS
25 May 2013
Search
The Pharma Letter
Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe
Goserelin Acetate Implant Articles
Russian prostate cancer market expected to grow 6% annually from 2011 to 2016
1 November 2012
US FDA calls for heart/diabetes risk warnings for class of prostate cancer drugs
21 October 2010
AstraZeneca reaches $103 million settlement over “inflated” drug prices in USA
21 June 2010
AstraZeneca bids $15.6B for MedImmune; posts 13% 1st-qtr 2007 EPS rise
30 April 2007
Showing 1-4 of 4 articles
1
Hot Topics
Most Read
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
Proposal to list Roche's Neulastim and Actemra in New Zealand
Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth